Marcia Belvin

13.0k citations

75 papers · 7.2k · 4 hit papers · h-index 38

Impact in

Immunology top 0.5%
- Invertebrate Immune Response Mechanisms
- Immune Response and Inflammation
- Aquaculture disease management and microbiota
Insect Science top 0.2%
- Insect symbiosis and bacterial influences

Papers in

Molecular Biology 51
- PI3K/AKT/mTOR signaling in cancer 19
- Melanoma and MAPK Pathways 18
- Protein Kinase Regulation and GTPase Signaling 7
Oncology 24
- Cancer Treatment and Pharmacology 6
- Cancer-related Molecular Pathways 6

Co-authors: Kathryn V. Anderson (3 shared papers)Lori S. Friedman (29 shared papers)Vanessa Gobert (3 shared papers)Dominique Ferrandon (3 shared papers)Marie Gottar (3 shared papers)Jules A. Hoffmann (4 shared papers)Julien Royet (2 shared papers)Klaus P. Hoeflich (18 shared papers)
Journals: Cancer Research (16 papers)Clinical Cancer Research (5 papers)Blood (3 papers)Proceedings of the National Academy of Sciences (3 papers)Molecular Cancer Therapeutics (3 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Marcia Belvin

75 papers receiving 7.0k citations

Marcia Belvin's Hit Papers

align trajectories log scale

MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade 2016 · 536 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Immunity
2006 Cell
2002 Nature
1996 Annual Review of Cell and Developmental Biology

Peers

Countries citing papers authored by Marcia Belvin

Since Specialization

Citations

This map shows the geographic impact of Marcia Belvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcia Belvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcia Belvin more than expected).

Fields of papers citing papers by Marcia Belvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcia Belvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcia Belvin. The network helps show where Marcia Belvin may publish in the future.

Co-authors

The 25 scholars most cited alongside Marcia Belvin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcia Belvin Line = papers co-authored together Marcia Belvin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A CONSERVED SIGNALING PATHWAY: The Drosophila Toll-Dorsal Pathway Annual Review of Cell and Developmental Biology ·Marcia Belvin, Kathryn V. Anderson Hit paper breakdown →	1996	666
2	The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein Nature ·Marie Gottar, Vanessa Gobert, Tatiana Michel, Marcia Belvin, Geoffrey M. Duyk, Jules A. Hoffmann, Dominique Ferrandon, Julien Royet Hit paper breakdown →	2002	555
3	MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade Immunity ·Peter Ebert, Jeanne Cheung, Yagai Yang, Erin McNamara, Rebecca Hong, Марина Москаленко, Stephen E. Gould, Heather Maecker, Bryan Irving, Jeong Kim, Marcia Belvin, Ira Mellman Hit paper breakdown →	2016	536
4	In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models Clinical Cancer Research ·Klaus P. Hoeflich, Carol O’Brien, Zachary Boyd, Guy Cavet, Steve Guerrero, Kenneth Jung, Tom Januario, Heidi Savage, Elizabeth A. Punnoose, Tom Truong, Wei Zhou, Leanne Berry, Lesley Murray, Lukas C. Amler, Marcia Belvin, Lori S. Friedman, Mark R. Lackner	2009	386
5	Dual Detection of Fungal Infections in Drosophila via Recognition of Glucans and Sensing of Virulence Factors Cell ·Marie Gottar, Vanessa Gobert, Alexey A. Matskevich, Jean‐Marc Reichhart, Chengshu Wang, Tariq M. Butt, Marcia Belvin, Jules A. Hoffmann, Dominique Ferrandon Hit paper breakdown →	2006	358
6	Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53 Cell ·Michael Ollmann, Lynn Young, Charles J. Di Como, Felix Karim, Marcia Belvin, Stephanie Robertson, Kellie Whittaker, Madelyn Demsky, William W. Fisher, Andrew R. Buchman, Geoffrey M. Duyk, Lori S. Friedman, Carol Prives, Casey Kopczynski	2000	338
7	A genome-wide analysis of immune responses in Drosophila Proceedings of the National Academy of Sciences ·Phil Irving, Laurent Troxler, Timothy S. Heuer, Marcia Belvin, Casey Kopczynski, Jean‐Marc Reichhart, Jules A. Hoffmann, Charles Hétru	2001	328
8	Dual Activation of the Drosophila Toll Pathway by Two Pattern Recognition Receptors Science ·Vanessa Gobert, Marie Gottar, Alexey A. Matskevich, Sophie Rutschmann, Julien Royet, Marcia Belvin, Jules A. Hoffmann, Dominique Ferrandon	2003	324
9	Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. The Journal of Immunology ·James D. Griffin, Olivier Spertini, T J Ernst, Marcia Belvin, H. B. Levine, Yuzuru Kanakura, Thomas F. Tedder	1990	277
10	Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice Nature Communications ·Janet Lau, Jeanne Cheung, Armando Navarro, Steve Lianoglou, Benjamin Haley, Klára Tótpál, Laura Sanders, Hartmut Koeppen, Patrick Caplazi, Jacqueline McBride, Henry Chiu, Rebecca Hong, Jane L. Grogan, Vincent Javinal, Robert L. Yauch, Bryan Irving, Marcia Belvin, Ira Mellman, Jeong Kim, Maike Schmidt	2017	273
11	A serpin mutant links Toll activation to melanization in the host defence of Drosophila The EMBO Journal ·Petros Ligoxygakis, Nadège Pelte, Chuanyi Ji, Vincent Leclerc, Bernard Duvic, Marcia Belvin, Haobo Jiang, Jules A Hoffmann, Jean‐Marc Reichhart	2002	240
12	Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3′ Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models Clinical Cancer Research ·Carol O’Brien, Jeffrey J. Wallin, Deepak Sampath, Debraj GuhaThakurta, Heidi Savage, Elizabeth A. Punnoose, Jane Guan, Leanne Berry, Wei Wei Prior, Lukas C. Amler, Marcia Belvin, Lori S. Friedman, Mark R. Lackner	2010	201
13	Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition Cancer Research ·Klaus P. Hoeflich, Mark Merchant, Christine Orr, Jocelyn Chan, Doug Den Otter, Leanne Berry, Ian Kasman, Hartmut Koeppen, Ken Rice, Nai-Ying Yang, Stefan Engst, Stuart H. Johnston, Lori S. Friedman, Marcia Belvin	2011	200
14	Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells Proceedings of the National Academy of Sciences ·Christy C. Ong, Adrian M. Jubb, Peter M. Haverty, Wei Zhou, Victoria Tran, Tom Truong, Helen Turley, (unknown), Domagoj Vucic, Adrian L. Harris, Marcia Belvin, Lori S. Friedman, Elizabeth M. Blackwood, Hartmut Koeppen, Klaus P. Hoeflich	2011	170
15	ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors Molecular Cancer Therapeutics ·Georgia Hatzivassiliou, Bonnie Liu, Carol O’Brien, Jill M. Spoerke, Klaus P. Hoeflich, Peter M. Haverty, Robert Soriano, William F. Forrest, Sherry Heldens, Huifen Chen, Karen Toy, Connie Ha, Wei Zhou, Kyung Song, Lori S. Friedman, Lukas C. Amler, Garret M. Hampton, John G. Moffat, Marcia Belvin, Mark R. Lackner	2012	158
16	An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer Cancer Research ·Mark L. McCleland, Adam S. Adler, Yonglei Shang, Thomas Hunsaker, Tom Truong, David Peterson, Eric Torres, Li Li, Benjamin Haley, Jean-Philippe Stéphan, Marcia Belvin, Georgia Hatzivassiliou, Elizabeth M. Blackwood, Laura Corson, Marie Evangelista, Jiping Zha, Ron Firestein	2012	156
17	Cactus protein degradation mediates Drosophila dorsal-ventral signaling. Genes & Development ·Marcia Belvin, Yishi Jin, Kathryn V. Anderson	1995	149
18	Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression Cancer Research ·Klaus P. Hoeflich, Sylvia Herter, Janet Tien, Leo Lap-Yan Wong, Leanne Berry, Jocelyn Chan, Carol O’Brien, Zora Modrušan, Somasekar Seshagiri, Mark R. Lackner, Howard M. Stern, Edna F. Choo, Lesley Murray, Lori S. Friedman, Marcia Belvin	2009	144
19	The Drosophila dCREB2 Gene Affects the Circadian Clock Neuron ·Marcia Belvin, Hong Zhou, Jerry C.P. Yin	1999	126
20	The Drosophila Immune Defense against Gram-Negative Infection Requires the Death Protein dFADD Immunity ·Silvia Naitza, Carine Rossé, Christine Kappler, Philippe Georgel, Marcia Belvin, David Gubb, Jacques Camonis, Jules A. Hoffmann, Jean-Marc Reichhart	2002	126

About Marcia Belvin

Marcia Belvin is a scholar working on Molecular Biology, Oncology, Immunology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 75 papers that have together received 7.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (19 papers), Melanoma and MAPK Pathways (18 papers), Invertebrate Immune Response Mechanisms (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Cancer Treatment and Pharmacology (6 papers), Cancer-related Molecular Pathways (6 papers) and Advanced Breast Cancer Therapies (6 papers). The work is most often cited by research in Immunology (3.0k citations), Insect Science (1.4k citations), Oncology (1.7k citations), Aging (119 citations) and Microbiology (380 citations). Marcia Belvin has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Kathryn V. Anderson, Lori S. Friedman, Vanessa Gobert, Dominique Ferrandon, Marie Gottar, Jules A. Hoffmann, Julien Royet, Klaus P. Hoeflich, Jean‐Marc Reichhart and Geoffrey M. Duyk. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Blood, Proceedings of the National Academy of Sciences and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Marcia Belvin

Impact in

Papers in i

In The Last Decade

Marcia Belvin

Marcia Belvin's Hit Papers

Peers

Countries citing papers authored by Marcia Belvin

Fields of papers citing papers by Marcia Belvin

All Works

About Marcia Belvin

Explore authors with similar magnitude of impact

Papers in